Entero Therapeutics Inc (ENTO)
1.76
-0.01
(-0.65%)
USD |
NASDAQ |
Jun 25, 16:00
1.73
-0.03
(-1.70%)
After-Hours: 20:00
Entero Therapeutics Cash from Investing (Quarterly): 0.0882M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0882M |
| December 31, 2023 | -0.50M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -10.25M |
| September 30, 2021 | 0.0025M |
| June 30, 2021 | -0.0739M |
| March 31, 2021 | |
| December 31, 2020 | 0.0902M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.0015M |
| March 31, 2020 | -0.0043M |
| December 31, 2019 | -0.0069M |
| September 30, 2019 | -0.0039M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.0134M |
| December 31, 2018 | -0.2571M |
| September 30, 2018 | -0.0073M |
| June 30, 2018 | -0.0115M |
| March 31, 2018 | -0.0295M |
| December 31, 2017 | -0.0002M |
| September 30, 2017 | -0.0107M |
| June 30, 2017 | -0.0207M |
| March 31, 2017 | -0.0006M |
| December 31, 2016 | 0.0008M |
| September 30, 2016 | -0.0015M |
| June 30, 2016 | -0.0107M |
| March 31, 2016 | -0.0009M |
| December 31, 2015 | -0.0045M |
| September 30, 2015 | -0.0068M |
| June 30, 2015 | -0.0021M |
| March 31, 2015 | -0.011M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-10.25M
Minimum
Dec 2021
0.0902M
Maximum
Dec 2020
-0.8196M
Average
--
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.747M |
| Cash from Financing (Quarterly) | 3.379M |
| Free Cash Flow | -13.28M |
| Free Cash Flow Per Share (Quarterly) | -0.2582 |
| Free Cash Flow Yield | -182.2% |